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Abstract
To investigate the foot-and-mouth disease virus (FMDV) serotypes circulating in Uganda’s cat-
tle population, both serological and virological analyses of samples from outbreaks that oc-
curred during 2012–2013 were performed. Altogether, 79 sera and 60 oropharyngeal fluid (OP)/
tissue/oral swab samples were collected from herds with reported FMD outbreaks in seven dif-
ferent Ugandan districts. Overall, 61/79 (77%) of the cattle sera were positive for antibodies
against FMDV by PrioCHECK FMDVNSELISA and solid phase blocking ELISA detected titres
 80 for serotypes O, SAT 1, SAT 2 and SAT 3 in 41, 45, 30 and 45 of these 61 seropositive
samples, respectively. Virus neutralisation tests detected the highest levels of neutralising anti-
bodies (titres 45) against serotype O in the herds from Kween and Rakai districts, against
SAT 1 in the herd fromNwoya district and against SAT 2 in the herds from Kiruhura, Isingiro
and Ntungamo districts. The isolation of a SAT 2 FMDV from Isingiro was consistent with the
detection of high levels of neutralising antibodies against SAT 2; sequencing (for the VP1 cod-
ing region) indicated that this virus belonged to lineage I within this serotype, like the currently
used vaccine strain. From theWakiso district 11 tissue/swab samples were collected; serotype
A FMDV, genotype Africa (G-I), was isolated from the epithelial samples. This study shows that
within a period of less than one year, FMD outbreaks in Uganda were caused by four different
serotypes namely O, A, SAT 1 and SAT 2. Therefore, to enhance the control of FMD in Uganda,
there is need for efficient and timely determination of outbreak virus strains/serotypes and vac-
cine matching. The value of incorporating serotype A antigen into the imported vaccines along
with the current serotype O, SAT 1 and SAT 2 strains should be considered.
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Introduction
Foot-and-mouth disease (FMD) is a highly infectious disease of cloven hoofed animals character-
ized by the formation of vesicles in, and around, the mouth and on the feet [1–3]. The disease is
caused by infection with FMDV (genus Aphthovirus, family Picornaviridae) which exists in
seven antigenically diverse serotypes (O, A, C, Asia 1, SAT 1, SAT 2 and SAT 3) [4, 5] that cause
indistinguishable clinical disease [6]. FMD is endemic in Uganda with outbreaks occurring fre-
quently [7]; cattle can show overt clinical signs, while it is generally subclinical in small ruminants
[1, 8, 9]. Although mortality is generally low, this disease causes significant economic losses
through reduction in milk production, loss of draught power and loss of access to profitable in-
ternational livestock and livestock product markets [10–12]. Thus, control of this disease holds
the potential to enhance food security, poverty alleviation and national development [11, 13].
In Uganda, control strategies for FMD outbreaks include quarantine and ring vaccination of
cattle using imported trivalent vaccines (O, SAT 1 and SAT 2) [14]. However, the success of
these efforts is hampered by uncontrolled animal movements, inadequate surveillance and de-
layed reporting of FMD outbreaks. Since vaccination against one of the seven FMDV serotypes
does not protect against other serotypes [15], it is important to know which serotypes are circu-
lating. Moreover, variation between FMDV strains within a given serotype may result in poor
coverage and may necessitate matching of one or more vaccine strains against the circulating
FMDVs [16], which is still a challenge in East Africa [17].
According to Vosloo et al.[6], all FMDV serotypes, other than Asia 1, have been detected in
East Africa, however, serotype C has not been isolated since 2004 [18, 19]. In Uganda, the first
FMD outbreak in cattle was reported in 1953 [7], with serotype O being responsible for the ma-
jority of the subsequent outbreaks. According to recent studies on Ugandan outbreaks from
2006 to 2011, topotype EA-2 serotype O FMDVs have been isolated, while the current O sero-
type vaccine strain incorporated in the imported trivalent vaccines belongs to the EA-1 topo-
type [20–22]. Other than serotype O FMDV, serotype A and SAT 2 viruses have been
identified in cattle in 2002 and 2004, respectively [14, 23], while serotypes SAT 1, SAT 2 and
SAT 3 FMDVs have been reported in Ugandan African buffalo (Syncerus caffer) [24, 25]. Very
recent characterization of Ugandan and Kenyan FMDV outbreak strains disclosed simulta-
neous outbreaks with different strains of serotype O [22, 26] and separately SAT 2 viruses [27],
emphasizing the necessity for prompt and accurate diagnosis, including regular typing of circu-
lating strains, for effective control measures to be implemented [28].
Uganda is currently at stage 1 of the FAO/OIE defined Progressive Control Pathway for
FMD (PCP-FMD) [17, 28] and to progress along this pathway, towards improved control of
FMD, it is important to generate more knowledge about the epidemiology of FMD in the coun-
try. The aim of this study was to characterize the FMDVs responsible for seven of the Ugandan
2012–2013 FMD outbreaks in cattle.
Materials and Methods
Study area, sampling strategy and sample collection
This study was performed using outbreak samples collected from Ugandan districts with re-
ported FMD outbreaks in 2012–2013. In 2012, 33 cattle sera were submitted to the National
Animal Disease Diagnostic and Epidemiological Centre (NADDEC) from three districts (Kiru-
hura, Kween and Nwoya) (Fig. 1). In 2013, oral epithelial tissues, oral swabs and/or oropharyn-
geal fluids (OPs) were collected from one outbreak herd in each of Isingiro, Ntungamo, Rakai
and Wakiso districts and in addition sera were collected from these herds in Isingiro, Ntun-
gamo and Rakai, totaling 46 sera, 30 OPs, 16 epithelial tissues and 14 oral swabs. These samples
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were collected following requests by the respective District Veterinary Officers (DVOs) and
subsequent approval by the Commissioner Animal Health, Ministry of Agriculture Animal In-
dustry and Fisheries. The DVOs sought the consent of each herd owner before sampling, and
samples were collected from, Isingiro District (GPS: 36M 0248868, UTM 9918082), Ntungamo
District (GPS: 36M 019262, UTM 989192), Rakai District (GPS: 36M 0315178, UTM 9894397)
andWakiso District (GPS: 36N 0447204, UTM 0041487). No GPS coordinates are available for
the samples submitted in 2012.The farmers were interviewed about the suspected source of the
Figure 1. The location of reported FMD outbreaks within Uganda in 2012–2013. The map shows the seven districts of Uganda that reported FMD
outbreaks during 2012–2013. These districts were: Kiruhura, Kween and Nwoya during the 2012 outbreaks plus Isingiro, Ntungamo, Rakai andWakiso
during the 2013 outbreaks.
doi:10.1371/journal.pone.0114811.g001
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outbreak, previous outbreaks, last vaccination and type of vaccine used, while the DVOs were
interviewed about the history of outbreaks and vaccination, the vaccine used and the instituted
control measures.
The epithelial tissues were preserved in 50% phosphate buffered saline (PBS) and 50% glyc-
erol while the oral swabs and OPs were preserved using PBS as recommended by OIE [16].
Sera were extracted from blood samples and stored at -20°C at NADDEC, while epithelial tis-
sues, OPs and oral swabs were kept in liquid nitrogen during transportation to NADDEC and
then stored at -80°C.
Laboratory methods
Detection of antibodies against FMDV non-structural proteins (NSPs). Sera were screened
for antibodies against FMDV NSPs using the PrioCHECK FMDV NS kit (Prionics AG, Zurich
Switzerland) following the manufacturer’s instructions except that optical density (OD) values
were measured at dual wavelengths (450 nm and 620 nm) using a Multiskan Ascent spectro-
photometer (Thermo Labsystems Oy, Helsinki, Finland). Results were expressed as percentage
inhibition (PI) relative to the mean of the negative controls; PI = 100—((OD of test sample
(OD450—OD620)/OD of mean negative control (OD450—OD620)) ×100), and sera with PI
50% were considered positive.
Detection of serotype-specific antibodies against FMDV using solid phase blocking ELI-
SAs (SPBE). All samples that were positive in the Priocheck FMDV NS ELISA were tested for
antibodies against each of the seven FMDV serotypes using SPBEs as described [8]. Screening
was done using a sample dilution of 1:10 and the results expressed as optical density percentage
(ODP) using the formula; ODP = (OD of test sample (OD450nm–620nm) / mean OD of negative
controls (OD450nm–620nm)) × 100. Samples were regarded as positive if ODP values were equal
to or lower than: 50% for serotypes O, SAT 1, SAT 2 and SAT 3, 45% for serotype A and 35%
for serotypes C and Asia 1 [8].
Positive reactions were titrated in the appropriate SPBEs (using two-fold dilution series
from 1:10 to 1:1280). Titres were expressed as the reciprocal of the highest positive dilution
and titres 80 were considered positive for each serotype [22].
Detection of serotype-specific neutralising antibodies against FMDV using virus neu-
tralization tests (VNTs). For each district, selected, representative samples with titres 80 in
the SPBEs were tested in the corresponding VNTs for the presence of neutralising antibodies.
The protocol was adapted from the procedure described in the OIE terrestrial manual [16] and
was described previously [22]. Briefly, two-fold serum dilutions were reacted for 1 hour with
100 TCID50 of virus suspension (O Manisa, A Iraq 24/64, C Noville, Asia 1 IND 8/79, SAT 1
BOT/68, SAT 2 ZIM 5/81 or SAT 3 ZIM 4/81) in equal volumes, in 96-well plates. Subsequent-
ly, swine kidney cell suspension was added to the wells and the plates were incubated at 37°C
for three days. The plates were examined for cytopathic effect (CPE) under the microscope and
the 50% end-point titres were calculated according to Reed and Muench, [29]. A titre 45 was
considered positive, 16 – 44 was considered doubtful and< 16 negative.
Detection of FMDV by virus isolation (VI). Epithelial tissue preparation and VI proce-
dures were adapted from the description in the OIE terrestrial manual [16] as described [25].
Briefly, samples (OPs or oral swab suspension or 10% suspension of epithelial tissues in Eagles
minimal essential medium including 2 million I.U. benzylpenicillin, 1g dihydro-streptomycin
sulphate, 0.5g neomycin sulphate and 8.5¼g amphotericin per litre (MEM+)) were inoculated
onto monolayers of primary bovine thyroid (BTY) cells in five wells using a dilution of 1:2 and
in five wells using a dilution of 1:4 in a 96 well tissue culture plate. Epithelial samples were cul-
tured on separate plates, while for OPs/oral swabs, samples from the same herd were cultured
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on the same plate but separated by wells with uninfected cells. The plates were incubated for 2
hours at 37°C (with 5% CO2), followed by a wash with MEM+ including 2% fetal calf serum
(FCS) and addition of 150μl MEM+ with 2% FCS per well. The plates were incubated for 1–2
days, as above, and observed for CPE every 24 hours. CPE-positive samples were frozen for
harvesting, while samples without CPE after 48 hours were harvested by freeze-thawing and
passaged again on BTY monolayers as described above. All samples that did not show CPE fol-
lowing the second passage were considered negative.
Confirmation of FMDV in CPE-positive samples by antigen ELISA (Ag ELISA). CPE-
positive harvests from all districts were tested in the Lindholm in-house antigen ELISA follow-
ing a protocol based on the description in the OIE terrestrial manual [16] as described [25].
Samples giving ODs> 0.2 higher than the negative control were considered positive, while
those with ODs 0.1—0.2 above the negative control were inconclusive and those with ODs
< 0.1 above the negative control were considered negative.
FMDV RNA extraction and detection using quantitative RT-PCR (RT-qPCR). RNA was
extracted from FMDV antigen positive cell culture harvests using the Blood kit Viral RNA
Mini Spin Protocol in the QIAamp Viral RNAMini Kit (Qiagen, Hamburg, Germany). cDNA
was synthesized using the Perkin Elmer (PE) Biosystem TaqMan kit (Perkin Elmer, Foster city,
California, USA) and RT-qPCR was performed using the TaqMan PCR kit (PE Applied Biosys-
tems, Foster city, California, USA) with FMDV 3D-F (ACTGGGTTTTACAAACCTGTGA)
and FMDV 3D-R (GCG AGTCCTGCG ACG GA) primers and the 3D-P probe
(TCCTTTGCACGCCGTGGGAC) labelled with 6-carboxyfluorescein as a reporter dye and
tetramethylrhodamine as a quencher at the 50 and 30 ends respectively [30].
cDNA synthesis and sequencing of FMDV VP1 coding region. The cDNA for sequencing
was synthesized using Ready-To-Go You-Prime First-strand Beads (GE Healthcare Life Sci-
ences, Uppsala, Sweden) according to the manufacturer’s instructions using 28μl template and
7μl of a four primer mix (85 ¼l of pdN6 random hexamer (50 ng/¼l), 5 ¼l of T27V
(TTTTTTTTTTTTTTTTTTTTTTTTTTTV) (25 pmol/¼l), 5 ¼l of KDS 1R (CCAGTCCCC-
TTCTCAGATC) (25 pmol/¼l) and 5 ¼l of 9-G PN 55 (GGGGGGGGGGGGGGH) (25 pmol/
¼l)). The PCR products corresponding to the VP1-coding region were prepared for sequencing
as previously described [20] except that the SAT 2 primers used were the forward 13-K PN 100
(50–30 GGGTGGBBGTSTWMCAGRTSACMGACAC) and reverse 1-O PN 15 (50–30
GAAGGGCCCAGGGTTGGACTC) (where B is C or G or T; S is G or C, W is A or T, M is A
or C, R is A or G). For serotype A samples, the primers used were forward 13-K PN 101 (50–30
CACTGCTAYCAYKCNGARTGGGA) and reverse 10-P PN 34 (50–30 CAGGGTTGGACTC-
MACGTCTCC) (where M is A or C; Y is T or C; K is G or T; R is G or A and N is G or A or T
or C). All primers were used at a concentration of 5 pmol/μl.
Gel purification of the PCR amplicons (795–942 bp) was performed using the GeneJET PCR
purification kit (Thermo Fisher Scientific). Cycle sequencing was performed with 10–15 ng of
PCR product (as determined using a Nanodrop spectrophotometer (Thermo Scientific, Wil-
mington, DE, USA)) and the BigDye terminator v3.1 cycle sequencing kit (Applied Biosystems,
Foster City California, USA) on an ABI 3700 automated DNA Sequencer (Applied Biosystems).
Data analysis
Descriptive serological data were entered in Microsoft Excel and imported into Stata 9 (Stata-
corp, Lakeway Drive College Station, Texas, USA) where the analysis was performed using the
median and interquartile range as a measure of central tendency and spread respectively. For
molecular data, base calling of nucleotide sequences was performed using seqMan Pro software
(Lasergene package, DNAstar, Inc., WI, USA). Published sequences relevant to this study were
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obtained using BLAST searches from NCBI (http://www.ncbi.nlm.nih.gov/)[31]. The se-
quences analyzed correspond to the VP1 coding region and details of the new and previously
published sequences are summarised in Table 1. Multiple sequences were aligned using MUS-
CLE (codons) [32] incorporated in MEGA 5 [33]. A phylogenetic tree of these sequences was
estimated using the Neighbor-Joining method [34]. The percentage of replicate trees in which
the associated taxa clustered together in the bootstrap test (2000 replicates) is shown next to
the branches [35]. The tree is drawn to scale with branch lengths in the same units as those of
the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were
computed using the Tamura 3-parameter method [36] and are in the units of the number of
base substitutions per site. The rate variation among sites was modelled with a gamma distribu-
tion (shape parameter = 1). The analysis for serotype A and SAT 2 involved 24 and 17 different
nucleotide (nt) sequences, respectively, and codon positions included were 1st+2nd+3rd. There
were a total of 638 and 648 nt positions in the final dataset for serotype A and SAT 2, respec-
tively. Evolutionary analyses were conducted in MEGA 5 [33].
Ethical approval
This research is part of a larger ongoing strategic project ‘Transboundary Animal Diseases in
East Africa’. Ethical approval for the project was granted by the Ministry of Agriculture Animal
Industry and Fisheries, Uganda (Reference LHE 199/01).
Results
Detection of antibodies against FMDV NSPs
Altogether 61 of the 79 (77%) cattle sera collected from herds with reported FMD outbreaks
had antibodies against the FMDV NSPs with herd prevalences ranging from 33% to 93%
(Table 2).
Detection of serotype-specific antibodies against FMDV using SPBE
Antibody titres 80 against one or more of all serotypes except Asia 1 were found using
SPBEs in 59 of the 61 samples that had tested positive for antibodies against FMDV NSPs.
Thus, 41, 7, 1, 45, 30 and 45 samples had SPBE titres 80 against serotypes O, A, C, SAT 1,
SAT 2 and SAT 3, respectively (Table 2). One sample with titre 80 in SPBE for antibodies
against C FMDV (from Isingiro) and four of the seven samples with titres 80–160 in SPBE for
antibodies against A FMDV (from Kween) had much higher titres against two or more of sero-
types O, SAT 1, SAT 2 and SAT 3. A fifth sample from Kween and two samples from Ntun-
gamo had SPBE A titre 160 as the highest titre. Seven sera had titres 80 against only one
serotype (A: 1; SAT 1: 1; SAT 2: 3; SAT 3: 2), while 52 sera had titres 80 against multiple se-
rotypes (data for individual animals can be found in the S1 Table). An overall evaluation of
SPBE titres pointed towards the outbreaks in Nwoya and Ntungamo being caused by SAT 1
and SAT 2 FMDV, respectively, while the one in Kween was most likely caused by O FMDV
and the one in Rakai by either O or SAT 1 FMDV. The SPBE results were very complicated in
Isingiro and Kiruhura, where very high titres against three or more of serotypes O, SAT 1, SAT
2 and SAT 3 in most sera impeded a serotype-specific diagnosis based on these assays.
Detection of neutralising antibodies using VNTs
Serum samples with antibody titres 80 in a serotype-specific SPBE were tested in VNTs for
antibodies against the same serotype if sufficient serum was available. None of the SPBE anti-
body titres of 80–160 against serotype C and A were confirmed in the VNTs. Furthermore, all
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Table 1. Eastern Africa serotype A and SAT 2 FMDV sequences used for comparisons in this study.
Sequence Collection date District/ Country Accession number Serotype Genotype/ lineage Reference
U74/13* 26/04/2013 Wakiso, Uganda KP089984 A G-I This study
U75/13* 26/04/2013 Wakiso, Uganda KP089985 A G-I This study
K3/2013 2013 Thika, Kenya KJ440876 A G-I [39]
K148/2012 2012 Nakuru, Kenya KJ440874 A G-I [39]
K63/2009 2009 Narok, Kenya KJ440871 A G-I [39]
TAN/9/2009 13/06/2009 Njombe, Tanzania KF561693 A G-I [50]
TAN/45/2009 06/11/2009 Iringa, Tanzania KF561696 A G-I [50]
K73/2008 2008 Loitoktok, Kenya KJ440870 A G-I [39]
TAN/11/2008 01/08/2008 Iringa, Tanzania KF561690 A G-I [50]
A/TUR/25/2007 06/04/2007 Mus, Turkey FJ755125 A Iran-05 [51]
ETH/4/2007 07/12/2007 Ethiopia FJ798150 A G-VII [52]
SUD/3/2006 26/04/2006 Sudan GU566070 A G-IV [53]
A/TUR/12/2005 27/12/2005 Murdagi, Turkey FJ755100 A Iran-05 [51]
K44/2005 2005 Nakuru, Kenya KJ440869 A G-I [39]
K1/1997 1997 Meru North, Kenya KJ440865 A G-VII [39]
K9/1994 1994 Narok, Kenya KJ440863 A G-I [39]
SUD/1/85 6/12/1984 Soba, Sudan GU566068 A G-IV [53]
K67/1985 1985 Isiolo, Kenya KJ440858 A G-I [39]
K49/1984 1984 Narok, Kenya KJ440857 A G-I [39]
K293/1983 1983 Taita Taveta,Kenya KJ440855 A G-I [39]
K48/1981 1981 Kaliﬁ,Kenya KJ440852 A G-I [39]
K35/1980** 1980 Embu, Kenya KJ440846 A G-VII [39]
K5/1980** 1980 Kajiado, Kenya KJ440848 A G-1 [39]
UGA/13/66 1966 Uganda KF561705 A G-VII [50]
U30/13* 8/2/2013 Isingiro, Uganda KP089986 SAT 2 I This study
U35/13* 8/2/2013 Isingiro, Uganda KP089987 SAT 2 I This study
U45/13* 8/2/2013 Isingiro, Uganda KP089988 SAT 2 I This study
U69/13* 8/2/2013 Isingiro, Uganda KP089989 SAT 2 I This study
U73/13* 8/2/2013 Isingiro, Uganda KP089990 SAT 2 I This study
K125/12* 2012 Gucha, Kenya N/A SAT 2 I unpublished
EGY/13/2012 1/3/2012 Qualubia-Banha Egypt JX570622 SAT 2 VII [54]
EGY/9/2012 29/2/2012 El-Suiz, Egypt JX570622 SAT 2 VII [54]
KEN/122/2009 1/1/2009 Rongai, Kenya JX570630 SAT 2 IV [54]
KEN/11/2009 2009 Kiambu, Kenya JX570628 SAT 2 IV [54]
TAN/43/2009 2009 Makete, Tanzania KF561727 SAT 2 IV [50]
K70/05 2005 Nairobi, Kenya HM623701 SAT 2 I [24]
UGA/11/2004 2004 Kiboga, Uganda GU323178 SAT 2 I [26]
TAN/6/2004 2004 Arusha, Tanzania KF561723 SAT 2 IV [50]
TAN/9/2004 2004 Arusha, Tanzania KF561724 SAT 2 IV [50]
K52/84** 1984 Nakuru, Kenya HM623685 SAT 2 I [24]
U267/83 1983 Uganda HM623682 SAT 2 I [24]
*: 2012–2013 Ugandan and one 2012 Kenyan outbreak FMDV sequences included in this study
**: vaccine strain sequencesN/A: means not available.
doi:10.1371/journal.pone.0114811.t001
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but three of 42 samples with SPBE antibody titres 80 against serotype SAT 3 were negative
or inconclusive in the corresponding VNT. However, the number of SPBE positive samples
with neutralising antibodies against serotypes O, SAT 1 and SAT 2 (titres 45) were 24/41,
13/38 and 25/25, respectively (Table 2). The VNTs determined high antibody titres against se-
rotype O FMDV in all tested sera from Kween and Rakai with lower titres against SAT 1 in
some sera from Rakai, while the detection of anti-SAT 1 antibodies in the SPBE was confirmed
for samples from Nwoya (Table 2). All SPBE positive sera from Ntungamo, Kiruhura and Isin-
giro tested in VNT had high neutralizing titres against SAT 2 FMDV with lower titres against
other serotypes in some sera (Table 2). The three sera with neutralising antibodies against SAT
3 came from three different herds/districts and had higher neutralising antibody titres against
at least one other serotype (O, SAT 1, SAT 2) (see S1 Table), indicating that these apparent
anti-SAT 3 reactions were likely cross reactivity generated by exposure to other serotypes.
Table 2. Summary of antibody analysis by PrioCHECK FMDV NS ELISA, SPBE antibody ELISAs and VNTs.
Districta No. of
samples
Anti-
NSP
positive
No. positive in SPBEb median titre (IQR) No. positive/no. tested in VNTc median titre
(IQR)
Conclusion
based on
serology
O SAT 1 SAT 2 SAT 3 O SAT 1 SAT 2 SAT 3
Kiruhurad 13 12 8 9 11 12 1/8 2/4 4/4 1/12 SAT 2f
480 640 1280 320 113 429 566 67
(320–1280) (320–1280) (320–1280) (320–320) (320–538) (170–1529)
Kweend 11 10 9 7 1 9 9/9 0/6 nd 0/9 O
640 320 80 320 269
(360–1280) (160–640) (320–320) (226–640)
Nwoyad 9 3 0 3 0 2 na 1/3 na 0/1 SAT 1
640 160 57
(160–1280) (160–160)
Isingiroe 23 20 15 16 18 17 6/15) 6/14 13/13 1/14 SAT 2
320 640 640 320 104 48 761 113
(80–640) (320–640) (320–1280) (80–480) (80–226) (48–67) (640–905)
Ntungamoe 13 10 3 4 9 4 2/3 1/4 7/7 1/4 SAT 2
80 120 160 240 81 80 190 80
(80–320) (80–160) (80–480) (120–480) (67–95) (160–269)
Rakaie 10 6 6) 6 1 1 6/6 3/6 nd 0/1 O
320 320 80 80 193 80
(320–640) (320–320) (160–320) (67–80)
Totals 79 61 41 45 40 45 24/41 13/38 25/25 3/4
a: one herd was sampled in each district
b: samples with titres  80 were considered positive (all anti-NSP positive samples were tested in all SPBEs).
c: samples with titre >45 were considered positive.
d: sera collected during 2012 outbreaks
e: sera collected during 2013 outbreaks
f: the two samples positive in SAT 1-VNT had higher titres in SAT 2-VNT (see S1 Table)
na: not applicable because all samples were negative in the SPBE
nd: not done
doi:10.1371/journal.pone.0114811.t002
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Virus characterization by VI, Ag ELISA, RT-qPCR and sequencing
Eight of 30 OPs, six of 16 epithelial samples and two of 14 oral swabs produced CPE during
one or two passages on primary BTY cells. These samples were from the districts of Isingiro
(eight), Ntungamo (two), Rakai (three) and Wakiso (three). The FMDV antigen ELISA identi-
fied serotype SAT 2 FMDV antigen in cell culture harvests from one OP, three epithelia and
one oral swab from Isingiro and serotype A FMDV antigen in those from three epithelia from
Wakiso (data not shown). Moreover, these eight virus harvests had Ct-values< 25 in RT-
qPCR assays. From these harvests, amplicons corresponding to the complete VP1 coding re-
gion were generated by RT-PCR and sequenced. The VP1 coding sequences, between 633 and
642 nucleotides in length, were determined and compared with other sequences from NCBI,
Genbank, using BLAST. The Isingiro and Wakiso sequences were most closely matched to
other SAT 2 and A FMDV sequences, respectively (Table 1), consistent with the Ag ELISA
data on these virus isolates. Identification of SAT 2 as the serotype responsible for the outbreak
in the Isingiro district was consistent with the high titres of neutralising antibodies against SAT
2 detected in the sera from this district (Table 2).
Phylogenetic analysis of serotype A FMDVs
Assessment of phylogenetic relationships using selected, genotype-defined serotype A FMDV
isolates (Table 1) showed that the VP1 sequences of the Wakiso strains (U74/2013 and U75/
2013) clustered with other strains belonging to the Africa genotype (G-I) (Fig. 2). The two
Wakiso strains had 100% nt identity with each other within the VP1 coding region and so had
the same predicted amino acid sequences (Fig. 3). The Wakiso viruses had pairwise nt identity
of 93% with both K3/2013 and K148/12 Kenyan isolates and amino acid (aa) identity of 93%
and 92% for K3/2013 and K148/12 respectively. Thus they belonged to the same lineage but
were in different sub-lineages [37–39]. The Wakiso sequences had pairwise nt identity of 82%
(521/633) and 82% (517/633), and pairwise aa identity of 87% and 89% (Fig. 3), with the K5/
1980 (Africa (G-I)) and K35/1980 (Africa (G-VII)) vaccine strains currently produced in
Kenya, respectively [40]. Hence, based on a cut off of> 15% nt difference in the VP1 coding re-
gion of FMDV (non-SAT serotypes) for separating genotypes [39, 41], these viruses belonged
to different genotypes than both the current Kenyan vaccine strains.
One hundred and twelve (18%) variable sites between the Wakiso serotype A VP1 sequences
and the vaccine strain (K5/1980) were determined across the 633 nucleotides, which encode
substitutions at 27/211 amino acids (13%) in the deduced protein sequence (Fig. 3). The integ-
rin receptor binding motif, RGD, (residues 144–146) within the Wakiso viruses was conserved
but there were a number of amino acid substitutions in the region flanking the RGD cell attach-
ment site (up to residues +3 and from -1 to -9). These amino acid variations occurred within
known antigenic regions; for example in antigenic site 1 [42, 43] methionine (M) was replaced
by leucine (L) at residue 147 while alanine (A) was replaced by glycine (G) at position 148.
Phylogenetic assessment of SAT 2 FMDVs
Except for one nucleotide substitution at position 339 (C for T) in the sequence of the virus iso-
late U35/13, the five Isingiro virus sequences from 2013 were identical within the VP1 coding
sequence. Assessment of phylogenetic relationships with selected SAT 2 FMDV isolates
(Table 1) showed that the five Isingiro viruses clustered with known strains belonging to the
SAT 2 lineage I (Fig. 4). Comparison of these recent viruses with the 2004 Ugandan SAT 2 cat-
tle isolate (UGA/11/2004), a partial VP1 sequence (345 nt), showed that they belonged to the
same genotype/lineage (pairwise nt identity of 90% (309/345 nt) and aa identity of 94% (108/
115 aa)) [4, 41]. However, based on the complete VP1 sequence, the Isingiro viruses were most
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closely related to a recent Kenyan isolate (K125/12) (Wekesa S., unpublished data) having a
pairwise nt identity of 99% and aa identity of 100%, and were also closely related to a Tanza-
nian isolate from 2009 (TAN/43/2009) (pairwise nt identity of 97% and aa identity of 98%).
The Ugandan 2013 SAT 2 sequences had 87% nt identity (557/642 nt) and pairwise aa iden-
tity of 94% with the SAT 2 vaccine strain (K52/84) which is incorporated in the trivalent vac-
cines (O, SAT 1 and SAT 2) currently used in Uganda. Therefore, these viruses belonged to the
same lineage as the vaccine strain.
Eighty five (13%) variable sites were determined across the 642 nt between the Isingiro 2013
SAT 2 outbreak sequences and the vaccine strain (K52/84) which encode substitutions of 12/
214 (6%) amino acids in the deduced protein sequence (Fig. 5). The RGDmotif (residues 144–
146) within these viruses was conserved and so was the flanking region of the RGD motif as far
as the -5 and +10 positions (Fig. 5). Conservative changes occurred at residue 138 where Asp
(D) was replaced by Glu (E) and at position 157 where Ser (S) was replaced by Thr (T), both
Figure 2. Neighbor-joining phylogeny tree based on serotype A FMDV VP1 coding sequences. The two 2013 Ugandan outbreak FMDV sequences are
marked with asterisks (*), and K35/1980** and K5/1980** are the current serotype A virus vaccine strains produced in Kenya and last used in Uganda in
2002. Bootstrap values greater than 50% are marked on the tree. Two of the three global topotypes within serotype A (Africa and Asia) are indicated, as are
some of the African genotypes found in Eastern Africa (G-I, G-IV and G- VII). The topotype Asia serotype A FMD viruses were used to out root the tree.
doi:10.1371/journal.pone.0114811.g002
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residues are located in the flanking region of the RGD motif cell attachment site [44, 45] which
also constitutes an important antigenic site.
Discussion
The aim of this study was to characterize the serotypes of FMDV responsible for Uganda’s
2012–2013 outbreaks. The detection of antibodies against FMDV NSPs in sera from herds with
recent reports of clinical signs of FMD strongly supported the clinical diagnosis. Moreover, the
higher seroprevalences (60–92%) of antibodies against FMDV NSPs in herds from Isingiro,
Kiruhura, Kween, Ntungamo and Rakai districts probably indicate that sampling was done
after considerable spread of the infection within these herds, while the lower seroprevalence in
the herd in Nwoya (33%) likely indicates sampling at an earlier phase of the outbreak [9].
Determining the serotype of the causal FMDV based on the SPBEs was not straightforward,
since 87% of the samples had antibody titres 80 against more than one serotype and with
most herds having high titres against serotypes O, SAT 1, SAT 2 and SAT 3. In addition, the
VNT also detected neutralising antibodies against more than one serotype in Ntungamo, Kiru-
hura and Isingiro. The cross-reactions observed between the SPBEs, and to a lesser extent be-
tween the VNTs, are in accordance with previous reports [9, 46–49], and have for the SPBEs
been observed to be more prominent for the first 1–4 weeks after experimental infection of
calves (Tjørnehøj, K., unpublished data). The detection of antibodies against multiple serotypes
may indicate some antigenic relationship between the virus serotypes [48], or could be due to a
Figure 3. Alignment of serotype A FMDV VP1 amino acid sequences. The VP1 amino acid sequences were inferred from one of the Ugandan 2013
serotype A FMDV nucleotide sequences (marked with an asterisk (*)) and selected African serotype A FMDV strains. The dots indicate identity with the
vaccine strain sequence (K5/1980**) that is the reference sequence.
doi:10.1371/journal.pone.0114811.g003
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complicated serological picture with heterotypic responses caused by priming effects from past
exposures from one or more infections and/or vaccinations [9, 46, 49]. Nevertheless, overall
evaluation of the SPBE titres limited the likely serotype responsible for the six outbreaks that
were investigated by serology to only one serotype for three outbreaks and to just two serotypes
in another outbreak. Moreover, the VNT, performed on selected SPBE positive sera, clearly
identified the responsible FMDV serotype in all six outbreaks (as O, SAT 1 or SAT 2).
The serological identification of SAT 2 as the responsible virus in Isingiro was confirmed by
the isolation of SAT 2 FMDV from clinical material. No serum samples were available from
the Wakiso district but serotype A FMDV was successfully isolated and characterized by anti-
gen ELISA and VP1 sequencing. Unfortunately, it was not possible to isolate viruses from the
samples collected from the outbreaks in Isingiro, Ntungamo and Rakai. However, the Isingiro
district borders the Kiruhura and Ntungamo districts, and since sera from these districts had
the highest antibody titres against SAT 2, it is not unlikely that the outbreaks in these districts
were all part of the same SAT 2 FMDV outbreak.
The 2013 outbreak of serotype A virus in the Wakiso district was close to the capital city
(Kampala); this serotype has not been reported in Uganda since 2002 [14]. The population of
cattle in this area is low and thus this FMD outbreak was suspected to have originated from an-
other country, possibly via feed or fomites or newly introduced animals. The two identical
Figure 4. Neighbor-joining phylogeny tree based on serotype SAT 2 FMDV VP1 coding sequences. The relationships between the Ugandan 2013 SAT
2 FMD viruses and selected East African SAT 2 viruses are shown. The five 2013 Ugandan and one 2012 Kenyan outbreak FMDV (K125/12) sequences are
marked with asterisks (*), while the strain K52/84** is the SAT 2 FMD virus strain incorporated in the trivalent vaccine (O, SAT 1 and SAT 2) as used in Uganda.
doi:10.1371/journal.pone.0114811.g004
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(within VP1) serotype A FMDVs belonged to a different sub-lineage from those recently found
in neighbouring Kenya (K148/2012 and K3/2013) (7% nt difference), hence, the Ugandan sero-
type A FMDV outbreak was not related to the Kenyan 2012–2013 outbreak. The VP1 sequence
of the isolates had 18% diversity from both the K5/1980 (G-I) and K35/1980 (G-VII) vaccine
strains. In fact, the Wakiso FMDVs cluster with viruses within a new genotype that has arisen
from within the Africa topotype (G-I) as discussed recently for Kenyan FMD viruses [40].
The five SAT 2 isolates from Isingiro were collected from a single epidemiological unit and
the VP1 coding sequences were identical except for one nt change in one of the five isolates
and belonged to lineage (I) within the SAT 2 strains. Moreover, these isolates were only distant-
ly related to the most recent Ugandan SAT 2 cattle isolate from 2004 (UGA/11/2004) (10% nt
difference) [26], but were closely related to a recent Kenyan isolate (K125/12) (1% nt differ-
ence) and a Tanzanian isolate from 2009 (TAN43/2009) (3% nt difference). This provides fur-
ther evidence for the transboundary mobility of FMDV in the East African region [20, 22],
probably due to the increased, uncontrolled, cross border movement given the growth of cross
border livestock trade [50]. The 2013 Ugandan SAT 2 VP1 sequences had 13% nt difference
from the vaccine strain (K52/84) which showed that they were rather different although be-
longing to the same genotype [41].
The current results indicate resurgence of serotypes A and SAT 2 FMDV in Uganda. The
significant diversity between both virus serotypes and their respective current vaccine strains
included multiple amino acid variations (Figs. 3 and 5), especially in the critical antigenic
Figure 5. Alignment of serotype SAT 2 FMDV VP1 amino acid sequences. The VP1 amino acid sequences were inferred from one of the 2013 outbreak
nucleotide sequences (marked with an asterisk (*)) and earlier SAT 2 FMDV strains. Identities with the reference vaccine strain sequence (K52/84**) are
indicated by dots. Similar amino acid variation exists between the reference sequence and the Ugandan 2013 isolates and a Kenyan outbreak isolate (K125/
12*) sequence (unpublished data).
doi:10.1371/journal.pone.0114811.g005
Circulation of Multiple Serotypes of FMDV in Uganda during 2012-2013
PLOS ONE | DOI:10.1371/journal.pone.0114811 February 9, 2015 13 / 17
regions. This indicates a need for vaccine matching studies to establish the level of protection
conferred against the currently circulating viruses by the available vaccine strains.
In conclusion, the presence of antibodies against FMDV in sera collected from six unvacci-
nated herds following reports of FMD outbreaks supported the FMD diagnosis, and the
FMDV serotypes responsible for the outbreaks were determined as O, SAT 1 and SAT 2 by the
use of SPBEs and VNTs. The serology based serotyping of the outbreaks was made more com-
plicated due to the cross-reactions identified with the SPBEs and also, to a lesser degree, with
VNTs. The FMDV responsible for one of these outbreaks was confirmed by isolation of sero-
type SAT 2 FMDV and the FMDV involved in a seventh outbreak was identified by isolation of
serotype A FMDV. The serotype A isolates were rather distantly related to the serotype A
FMDV vaccine strains incorporated in the vaccines imported to Uganda in 2002 [14]. In con-
trast, the Ugandan 2013 SAT 2 viruses belonged to the same lineage, (I), as the FMDV vaccine
strain incorporated in the trivalent vaccines (O, SAT 1 and SAT 2) imported by Uganda but
have amino acid substitutions within antigenic sites. Therefore, to enhance the control of FMD
in Uganda, there is need for increased surveillance, including monitoring with efficient and
timely characterization of outbreak virus strains, as well as vaccine matching. The value of in-
corporating an appropriate serotype A FMDV vaccine strain into the imported vaccines used
in Uganda should be assessed.
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